This is a serious condition where kidney function suddenly worsens in people with severe liver disease. The kidneys don't work properly, leading to fluid buildup and low urine output. It's often seen in cirrhosis.
Every report comes from a Lived member, sent anonymously.
Have you had Liver Transplant for Hepatorenal Syndrome?
Hepatorenal syndrome (HRS) is a form of kidney failure that develops in people with advanced liver disease, most often cirrhosis with ascites (fluid buildup in the belly). The kidneys themselves are not structurally damaged. Instead, severe liver disease disturbs blood flow through the body so much that the kidneys receive too little blood and stop filtering waste and fluid properly. Because the problem is in circulation rather than in the kidney tissue, HRS can be reversed if blood flow improves, especially with a liver transplant. It is still one of the most serious complications of cirrhosis, and it often signals that the liver disease has reached a dangerous stage. Doctors now describe two forms. HRS-AKI (acute kidney injury, formerly called type 1) is a rapid loss of kidney function over days and needs urgent hospital treatment. A slower, longer-lasting form (formerly type 2) develops over weeks to months and is often linked to ascites that is hard to control.
HRS grows out of portal hypertension, the high pressure in the veins that carry blood through a scarred liver. Over time, blood vessels in the abdomen widen and blood pools there, so the rest of the body behaves as if it is low on blood volume. The body responds by holding on to salt and water and tightening the blood vessels that supply the kidneys. When that tightening becomes severe, kidney function falls. An episode is often set off by something that puts extra strain on that fragile balance. Common triggers include infections, especially spontaneous bacterial peritonitis (an infection of the fluid in the abdomen), bleeding in the stomach or intestines, and draining a large amount of abdominal fluid without giving albumin (a blood protein given through a vein) to support circulation. Medicines can also contribute, including high doses of diuretics (water pills) and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve), which people with cirrhosis are generally advised to avoid. Sometimes no single trigger is found.
HRS is usually diagnosed in the hospital, often while someone is already being treated for complications of liver disease. Symptoms such as passing much less urine, swelling, nausea or confusion overlap with those of advanced cirrhosis, so blood tests are what reveal the problem. The key measurement is creatinine, a waste product the kidneys clear from the blood. A rise of 0.3 mg/dL or more within two days, or a rise of 50% or more from a person's usual level within a week, defines acute kidney injury in someone with cirrhosis. No single test proves HRS, so it is a diagnosis made by ruling other causes out. Doctors stop diuretics and give albumin for two days to see whether kidney function recovers; if it does, the cause was more likely dehydration or low blood volume. They also check for shock, recent use of medicines that can harm the kidneys, and signs of direct kidney damage, such as protein or blood in the urine or an abnormal kidney ultrasound. Because infection is a common trigger, testing usually includes a sample of abdominal fluid and blood and urine cultures.
Treatment starts by removing anything that could be making the kidneys worse: diuretics and NSAIDs are stopped, blood pressure medicines may be paused, and infections or bleeding are treated. Albumin is given through a vein to support blood volume. If kidney function does not recover, the main medical treatment combines albumin with a vasoconstrictor, a medicine that narrows the widened blood vessels in the abdomen so more blood reaches the kidneys. Terlipressin (Terlivaz), a hospital medicine related to the body's own vasopressin hormone, is the first choice in US and European guidance and is approved by the US Food and Drug Administration (FDA) to improve kidney function in adults with rapidly worsening HRS. It improves kidney function in a meaningful share of people, but it works less well when creatinine is already very high, and studies have not shown that it helps people live longer. It can cause serious or fatal breathing problems from fluid building up in the lungs, so oxygen levels are checked before starting and monitored throughout treatment. Norepinephrine is an alternative given by continuous infusion in an intensive care unit. A combination of midodrine (a blood pressure pill) and octreotide (an injected hormone-like drug) is weaker and is used mainly when the other two are not available. These medicines are best understood as a bridge rather than a cure. Liver transplant is the treatment that addresses the underlying cause, and people with HRS are usually evaluated for it. Most people's kidneys recover after a transplant, although up to about a quarter continue to have kidney problems; people whose kidneys have failed for a long time may be considered for a combined liver and kidney transplant. Dialysis can take over the kidneys' work when medicines fail and fluid, potassium or acid levels become dangerous, mainly while someone waits for a transplant or if a reversible cause is expected to improve.
HRS is a serious turning point in liver disease. The rapid form is treated in the hospital, often for several days or longer, with daily blood tests to see whether creatinine is falling, careful tracking of fluid and urine, and close monitoring while on vasoconstrictor treatment. Some people regain much of their kidney function with treatment. Others do not, particularly when the liver disease continues to worsen. The longer-term outlook depends mostly on the liver. Without a transplant, survival after HRS is often limited, which is why doctors usually raise transplant evaluation, and for those who are not candidates, conversations about goals of care, early on. After discharge, people typically have frequent blood tests and medication reviews, may need repeated fluid drainage for ascites, and are asked to avoid NSAIDs and to check with their care team before starting any new medicine or supplement. Families often take on a large share of this follow-up, and support from a hepatology team, social work and, where appropriate, palliative care can make it more manageable.
If you have cirrhosis, keep regular appointments for blood tests that track kidney function, and ask your liver team before taking any new pain reliever or other medicine. Contact your care team the same day, or go to the hospital as they direct, if you notice much less urine than usual, new confusion or unusual drowsiness, fever or new belly pain or tenderness, or rapid weight gain or swelling. In someone with advanced liver disease, these changes can mean kidney function is falling or an infection has started, and early treatment matters because this condition can worsen quickly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hepatorenal Syndrome is like, what's helped you, or ask the community a question.